Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

qXR-CTR

K-Number: K231149 · 2023-09-22

Decision Date2023-09-22
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

qXR-CTR is a medical device manufactured by Qure.Ai Technologies. It received FDA 510(k) clearance on 2023-09-22 under approval number K231149. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the qXR-CTR?

qXR-CTR is a medical device that received FDA 510(k) clearance on 2023-09-22. It is manufactured by Qure.Ai Technologies. The 510(k) number is K231149.

When was qXR-CTR approved by the FDA?

qXR-CTR received FDA 510(k) clearance on 2023-09-22, under approval number K231149.

What company makes qXR-CTR?

qXR-CTR is manufactured by Qure.Ai Technologies.

What is the FDA product code for qXR-CTR?

The FDA product code for qXR-CTR is QIH.

Other Devices by Qure.Ai Technologies

View all 9 devices →

Related Devices (Code: QIH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.